Cellular and Molecular Biology of Optineurin

International Review of Cell and Molecular Biology

Volumn 294, Issue , 2012, Pages 223-258

  Ying, Hongyu ^a   Yue, Beatrice Y J T ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Amyotrophic lateral sclerosis; Functional consequence; Glaucoma; Localization; Molecular structure; Mutations; Optineurin

Indexed keywords

AMINO ACID; BINDING PROTEIN; CELL PROTEIN; GENOMIC DNA; HUNTINGTIN; I KAPPA B; MESSENGER RNA; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; MYOSIN VI; OPTINEURIN; PROTEIN CYLD; PROTEIN GABARAP; PROTEIN RAB8; PROTEIN TAX1; PROTEIN TAX1BPI1; PROTEIN TAX2; RIP1 PROTEIN; SERINE THREONINE KINASE RECEPTOR INTERACTING PROTEIN; TANK PROTEIN; TRANSCRIPTION FACTOR IIIA; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPHAGY; CELLULAR DISTRIBUTION; DATA ANALYSIS; DEGENERATIVE DISEASE; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE MUTATION; GLAUCOMA; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; MOLECULAR BIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84857387139     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394305-7.00005-7     Document Type: Chapter

References (164)

1. Albagha O.M., Visconti M.R., Alonso N., Langston A.L., Cundy T., Dargie R., et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat. Genet. 2010, 42:520-524.
2. Allingham R.R., Liu Y., Rhee D.J. The genetics of primary open-angle glaucoma: a review. Exp. Eye Res. 2009, 88:837-844.
3. Altman R.D., Bloch D.A., Hochberg M.C., Murphy W.A. Prevalence of pelvic Paget's disease of bone in the United States. J. Bone Miner. Res. 2000, 15:461-465.
4. Alward W.L., Kwon Y.H., Kawase K., Craig J.E., Hayreh S.S., Johnson A.T., et al. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am. J. Ophthalmol. 2003, 136:904-910.
5. Anborgh P.H., Godin C., Pampillo M., Dhami G.K., Dale L.B., Cregan S.P., et al. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J. Biol. Chem. 2005, 280:34840-34848.
6. Anderson D.R. Collaborative normal tension glaucoma study. Curr. Opin. Ophthalmol. 2003, 14:86-90.
7. Aschenbrenner L., Lee T., Hasson T. Myo6 facilitates the translocation of endocytic vesicles from cell peripheries. Mol. Biol. Cell 2003, 14:2728-2743.
8. Au J.S., Puri C., Ihrke G., Kendrick-Jones J., Buss F. Myosin VI is required for sorting of AP-1B-dependent cargo to the basolateral domain in polarized MDCK cells. J. Cell Biol. 2007, 177:103-114.
9. Aung T., Rezaie T., Okada K., Viswanathan A.C., Child A.H., Brice G., et al. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest. Ophthalmol. Vis. Sci. 2005, 46:2816-2822.
10. Ayala-Lugo R.M., Pawar H., Reed D.M., Lichter P.R., Moroi S.E., Page M., et al. Variation in optineurin (OPTN) allele frequencies between and within populations. Mol. Vis. 2007, 13:151-163.
11. Azmi P., Seth A. RNF11 is a multifunctional modulator of growth factor receptor signaling and transcriptional regulation. Eur. J. Cancer 2005, 41:2549-2560.
12. Bache K.G., Raiborg C., Mehlum A., Stenmark H. STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J. Biol. Chem. 2003, 278:12513-12521.
13. Baird P.N., Richardson A.J., Craig J.E., Mackey D.A., Rochtchina E., Mitchell P. Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study. Clin. Experiment. Ophthalmol. 2004, 32:518-522.
14. Baloyannis S.J., Mauroudis I., Manolides S.L., Manolides L.S. Synaptic alterations in the medial geniculate bodies and the inferior colliculi in Alzheimer's disease: a Golgi and electron microscope study. Acta Otolaryngol. 2009, 129:416-418.
15. Bao X.H., Naomoto Y., Hao H.F., Watanabe N., Sakurama K., Noma K., et al. Autophagy: can it become a potential therapeutic target?. Int. J. Mol. Med. 2010, 25:493-503.
16. Beyens G., Van Hul E., Van Driessche K., Fransen E., Devogelaer J.P., Vanhoenacker F., et al. Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif. Tissue Int. 2004, 75:144-152.
17. Bond L.M., Peden A.A., Kendrick-Jones J., Sellers J.R., Buss F. Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol. Biol. Cell 2011, 22:54-65.
18. Bonnard M., Mirtsos C., Suzuki S., Graham K., Huang J., Ng M., et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J. 2000, 19:4976-4985.
19. Brummelkamp T.P., Nijman S.M., Dirac A.M., Bernards R. Loss of cylindromatosis tumor suppressor inhibits apoptosis by activating NF-κB. Nature 2003, 424:797-801.
20. Buss F., Kendrick-Jones J., Lionne C., Knight A.E., Cote G.P., Paul Luzio J. The localization of myosin VI at the Golgi complex and leading edge of fibroblasts and its phosphorylation and recruitment into membrane ruffles of A431 cells after growth factor stimulation. J. Cell Biol. 1998, 143:1535-1545.
21. Buss F., Luzio J.P., Kendrick-Jones J. Myosin VI, a new force in clathrin mediated endocytosis. FEBS Lett. 2001, 508:295-299.
22. Buss F., Spudich G., Kendrick-Jones J. Myosin VI: cellular functions and motor properties. Annu. Rev. Cell Dev. Biol. 2004, 20:649-676.
23. Caixeta-Umbelino C., de Vasconcellos J.P., Costa V.P., Kasahara N., Della Paolera M., de Almeida G.V., et al. Lack of association between optineurin gene variants T34T, E50K, M98K, 691_692insAG and R545Q and primary open angle glaucoma in Brazilian patients. Ophthalmic Genet. 2009, 30:13-18.
24. Caviston J.P., Holzbaur E.L. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol. 2009, 19:147-155.
25. Chakrama F.Z., Seguin-Py S., Le Grand J.N., Fraichard A., Delage-Mourroux R., Despouy G., et al. GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy 2010, 6. 495-505.
26. Chi Z.L., Akahori M., Obazawa M., Minami M., Noda T., Nakaya N., et al. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum. Mol. Genet. 2010, 19:2606-2615.
27. Chibalina M.V., Roberts R.C., Arden S.D., Kendrick-Jones J., Buss F. Rab8-optineurin-myosin VI: analysis of interactions and functions in the secretory pathway. Methods Enzymol. 2008, 438:11-24.
28. Chu Z.L., Shin Y.A., Yang J.M., DiDonato J.A., Ballard D.W. IKKγ mediates the interaction of cellular IκB kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 1999, 274:15297-15300.
29. Chung P.Y., Beyens G., Boonen S., Papapoulos S., Geusens P., Karperien M., et al. The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum. Genet. 2010, 128:615-626.
30. Clemens K.R., Wolf V., McBryant S.J., Zhang P., Liao X., Wright P.E., et al. Molecular basis for specific recognition of both RNA and DNA by a zinc finger protein. Science 1993, 260:530-533.
31. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37:205-237.
32. De Marco N., Buono M., Troise F., Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J. Biol. Chem. 2006, 281:16147-16156.
33. del Toro D., Canals J.M., Gines S., Kojima M., Egea G., Alberch J. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J. Neurosci. 2006, 26:12748-12757.
34. del Toro D., Alberch J., Lazaro-Dieguez F., Martin-Ibanez R., Xifro X., Egea G., et al. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol. Biol. Cell 2009, 20:1478-1492.
35. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995, 14:1075-1081.
36. Dunn W.A. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J. Cell Biol. 1990, 110:1923-1933.
37. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNF-α requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 2006, 22:245-257.
38. Eskelinen E.L. Maturation of autophagic vacuoles in mammalian cells. Autophagy 2005, 1:1-10.
39. Falchetti A., Di Stefano M., Marini F., Del Monte F., Mavilia C., Strigoli D., et al. Two novel mutations at exon 8 of the Sequestosome 1 (SQSTM1) gene in an Italian series of patients affected by Paget's disease of bone (PDB). J. Bone Miner. Res. 2004, 19:1013-1017.
40. Fan J., Hu Z., Zeng L., Lu W., Tang X., Zhang J., et al. Golgi apparatus and neurodegenerative diseases. Int. J. Dev. Neurosci. 2008, 26:523-534.
41. Farquhar M.G., Palade G.E. The Golgi apparatus: 100 years of progress and controversy. Trends Cell Biol. 1998, 8:2-10.
42. Fujita Y., Ohama E., Takatama M., Al-Sarraj S., Okamoto K. Fragmentation of Golgi apparatus of nigral neurons with α-synuclein-positive inclusions in patients with Parkinson's disease. Acta Neuropathol. 2006, 112:261-265.
43. Fujita Y., Mizuno Y., Takatama M., Okamoto K. Anterior horn cells with abnormal TDP-43 immunoreactivities show fragmentation of the Golgi apparatus in ALS. J. Neurol. Sci. 2008, 269:30-34.
44. Funayama T., Ishikawa K., Ohtake Y., Tanino T., Kurosaka D., Kimura I., et al. Variants in optineurin gene and their association with tumor necrosis factor-α polymorphisms in Japanese patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2004, 45:4359-4367.
45. Fuse N., Takahashi K., Akiyama H., Nakazawa T., Seimiya M., Kuwahara S., et al. Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J. Glaucoma 2004, 13:299-303.
46. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
47. Gonatas N.K., Stieber A., Gonatas J.O. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 2006, 246:21-30.
48. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 2006, 38:411-413.
49. Guilherme A., Soriano N.A., Bose S., Holik J., Bose A., Pomerleau D.P., et al. EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J. Biol. Chem. 2004, 279:10593-10605.
50. Harhaj E.W., Sun S.C. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus TAX protein. J. Biol. Chem. 1999, 274:22911-22914.
51. Hattula K., Peranen J. FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr. Biol. 2000, 10:1603-1606.
52. Hauser M.A., Sena D.F., Flor J., Walter J., Auguste J., Larocque-Abramson K., et al. Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J. Glaucoma 2006, 15:358-363.
53. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol. 2009, 11:1433-1437.
54. Hemmi H., Takeuchi O., Sato S., Yamamoto M., Kaisho T., Sanjo H., et al. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 2004, 199:1641-1650.
55. Hocking L.J., Lucas G.J., Daroszewska A., Mangion J., Olavesen M., Cundy T., et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 2002, 11:2735-2739.
56. Hoffner G., Kahlem P., Djian P. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with β-tubulin: relevance to Huntington's disease. J. Cell Sci. 2002, 115:941-948.
57. Hoyng P.F., Kitazawa Y. Medical treatment of normal tension glaucoma. Surv. Ophthalmol. 2002, 47(Suppl. 1):S116-S124.
58. Huber L.A., de Hoop M.J., Dupree P., Zerial M., Simons K., Dotti C. Protein transport to the dendritic plasma membrane of cultured neurons is regulated by Rab8p. J. Cell Biol. 1993, 123:47-55.
59. Huber L.A., Pimplikar S., Parton R.G., Virta H., Zerial M., Simons K. Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J. Cell Biol. 1993, 123:35-45.
60. Ito H., Fujita K., Nakamura M., Wate R., Kaneko S., Sasaki S., et al. Optineurin is colocalized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol. 2011, 122:223-229.
61. Jin D.Y., Giordano V., Kibler K.V., Nakano H., Jeang K.T. Role of adapter function in oncoprotein-mediated activation of NF-κB: human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J. Biol. Chem. 1999, 274:17402-17405.
62. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
63. Journo C., Filipe J., About F., Chevalier S.A., Afonso P.V., Brady J.N., et al. NRP/optineurin cooperates with TAX1BP1 to potentiate the activation of NF-κB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog. 2009, 5:e1000521.
64. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
65. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117:2805-2812.
66. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 1997, 115:1031-1035.
67. Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34:259-269.
68. Knodler L.A., Vallance B.A., Celli J., Winfree S., Hansen B., Montero M., et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc. Natl. Acad. Sci. USA 2010, 107:17733-17738.
69. Koga T., Shen X., Park J., Qiu Y., Park B.C., Shyam R., et al. Effects of myocilin and optineurin, two glaucoma genes on neurite outgrowth. Am. J. Pathol. 2010, 176:343-352.
70. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 2003, 424:801-805.
71. Kremer B., Goldberg P., Andrew S.E., Theilmann J., Telenius H., Zeisler J., et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med. 1994, 330:1401-1406.
72. Kroeber M., Ohlmann A., Russell P., Tamm E.R. Transgenic studies on the role of optineurin in the mouse eye. Exp. Eye Res. 2006, 82:1075-1085.
73. Kuai J., Wooters J., Hall J.P., Rao V.R., Nickbarg E., Li B., et al. NAK is recruited to the TNFR1 complex in a TNFα-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach. J. Biol. Chem. 2004, 279:53266-53271.
74. Kuehn M.H., Fingert J.H., Kwon Y.H. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol. Clin. North Am. 2005, 18:383-395.
75. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
76. Kwon Y.H., Fingert J.H., Kuehn M.H., Alward W.L. Primary open-angle glaucoma. N. Engl. J. Med. 2009, 360:1113-1124.
77. Laurin N., Brown J.P., Morissette J., Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 2002, 70:1582-1588.
78. Lee S.J., Lim H.S., Masliah E., Lee H.J. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci. Res. 2011, 70:339-348.
79. Leigh P.N. Chapter 13 amyotrophic lateral sclerosis. Handb. Clin. Neurol. 2007, 82:249-278.
80. Leung Y.F., Fan B.J., Lam D.S., Lee W.S., Tam P.O., Chua J.K., et al. Different optineurin mutation pattern in primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3880-3884.
81. Li Y., Kang J., Horwitz M.S. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor α-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 1998, 18:1601-1610.
82. Liu Y., Akafo S., Santiago-Turla C., Cohen C.S., Larocque-Abramson K.R., Qin X., et al. Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma. Mol. Vis. 2008, 14:2367-2372.
83. Lucas G.J., Riches P.L., Hocking L.J., Cundy T., Nicholson G.C., Walsh J.P., et al. Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent. J. Bone Miner. Res. 2008, 23:58-63.
84. Magadan J.G., Barbieri M.A., Mesa R., Stahl P.D., Mayorga L.S. Rab22a regulates the sorting of transferrin to recycling endosomes. Mol. Cell. Biol. 2006, 26:2595-2614.
85. Mankouri J., Fragkoudis R., Richards K.H., Wetherill L.F., Harris M., Kohl A., et al. Optineurin negatively regulates the induction of IFNβ in response to RNA virus infection. PLoS Pathog. 2010, 6:e1000778.
86. Marsh B.J., Howell K.E. The mammalian Golgi-complex debates. Nat. Rev. Mol. Cell Biol. 2002, 3:789-795.
87. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
88. Matsui K., Kumagai Y., Kato H., Sato S., Kawagoe T., Uematsu S., et al. Cutting edge: role of TANK-binding kinase 1 and inducible IκB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 2006, 177:5785-5789.
89. McCray B.A., Taylor J.P. The role of autophagy in age-related neurodegeneration. Neurosignals 2008, 16:75-84.
90. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in TBK1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 2004, 101:233-238.
91. Meijer A.J., Codogno P. Autophagy: regulation and role in disease. Crit. Rev. Clin. Lab. Sci. 2009, 46:210-240.
92. Millecamps S., Boillee S., Chabrol E., Camu W., Cazeneuve C., Salachas F., et al. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32(557):e511-e553.
93. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
94. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
95. Morales-Piga A.A., Rey-Rey J.S., Corres-Gonzalez J., Garcia-Sagredo J.M., Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 1995, 10:663-670.
96. Moreland R.J., Dresser M.E., Rodgers J.S., Roe B.A., Conaway J.W., Conaway R.C., et al. Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res. 2000, 28:1986-1993.
97. Morino C., Kato M., Yamamoto A., Mizuno Z., Hayakawa A., Komada M., et al. A role of Hrs in endosomal sorting of ligand-stimulated and unstimulated epidermal growth factor receptor. Exp. Cell Res. 2004, 297:380-391.
98. Moritz O.L., Tam B.M., Hurd L.L., Peranen J., Deretic D., Papermaster D.S. Mutant rab8 Impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic Xenopus rods. Mol. Biol. Cell 2001, 12:2341-2351.
99. Morton S., Hesson L., Peggie M., Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008, 582:997-1002.
100. Mourelatos Z., Hirano A., Rosenquist A.C., Gonatas N.K. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in β, β'-iminodipropionitrile axonopathy. Am. J. Pathol. 1994, 144:1288-1300.
101. Mukhopadhyay A., Komatireddy S., Acharya M., Bhattacharjee A., Mandal A.K., Thakur S.K., et al. Evaluation of optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol. Vis. 2005, 11:792-797.
102. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
103. Nagabhushana A., Chalasani M.L., Jain N., Radha V., Rangaraj N., Balasubramanian D., et al. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol. 2010, 11:4.
104. Nagabhushana A., Bansal M., Swarup G. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation. PLoS One 2011, 6:e17477.
105. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75:822-831.
106. Osawa T., Mizuno Y., Fujita Y., Takatama M., Nakazato Y., Okamoto K. Optineurin in neurodegenerative diseases. Neuropathology 2011, 31:569-574.
107. Park B.C., Shen X., Samaraweera M., Yue B.Y.J.T. Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am. J. Pathol. 2006, 169:1976-1989.
108. Park S.Y., Cable A.E., Blair J., Stockstill K.E., Shannon K.B. BMC Cell Biol. 2009, 10:43-54.
109. Park B.C., Ying H., Shen X., Park J.S., Qiu Y., Shyam R., et al. Impairment of protein trafficking upon overexpression and mutation of optineurin. PLoS One 2010, 5:e11547.
110. Peranen J., Auvinen P., Virta H., Wepf R., Simons K. Rab8 promotes polarized membrane transport through reorganization of actin and microtubules in fibroblasts. J. Cell Biol. 1996, 135:153-167.
111. Perret E., Lakkaraju A., Deborde S., Schreiner R., Rodriguez-Boulan E. Evolving endosomes: how many varieties and why?. Curr. Opin. Cell Biol. 2005, 17:423-434.
112. Perrin A.J., Jiang X., Birmingham C.L., So N.S., Brumell J.H. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr. Biol. 2004, 14:806-811.
113. Quigley H.A. Glaucoma. Lancet 2011, 377:1367-1377.
114. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
115. Rao K.N., Nagireddy S., Chakrabarti S. Complex genetic mechanisms in glaucoma: an overview. Indian J. Ophthalmol. 2011, 59(Suppl.):S31-S42.
116. Rezaie T., Sarfarazi M. Molecular cloning, genomic structure, and protein characterization of mouse optineurin. Genomics 2005, 85:131-138.
117. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
118. Rezaie T., Waitzman D.M., Seeman J.L., Kaufman P.L., Sarfarazi M. Molecular cloning and expression profiling of optineurin in the rhesus monkey. Invest. Ophthalmol. Vis. Sci. 2005, 46:2404-2410.
119. Rezaie T., Stoilov I., Sarfarazi M. Embryonic expression of the optineurin (glaucoma) gene in different stages of mouse development. Mol. Vis. 2007, 13:1446-1450.
120. Robbins E., Gonatas N.K. The ultrastructure of a mammalian cell during the mitotic cycle. J. Cell Biol. 1964, 21:429-463.
121. Rong J., Li S.H., Li X.J. Regulation of intracellular HAP1 trafficking. J. Neurosci. Res. 2007, 85:3025-3029.
122. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
123. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10(Suppl.):S10-S17.
124. Sahlender D.A., Roberts R.C., Arden S.D., Spudich G., Taylor M.J., Luzio J.P., et al. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J. Cell Biol. 2005, 169:285-295.
125. Sakurai A., Okamoto K., Fujita Y., Nakazato Y., Wakabayashi K., Takahashi H., et al. Fragmentation of the Golgi apparatus of the ballooned neurons in patients with corticobasal degeneration and Creutzfeldt-Jakob disease. Acta Neuropathol. 2000, 100:270-274.
126. Sarfarazi M., Rezaie T. Optineurin in primary open angle glaucoma. Ophthalmol. Clin. North Am. 2003, 16:529-541.
127. Schwamborn K., Weil R., Courtois G., Whiteside S.T., Israel A. Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-κB-independent pathway. J. Biol. Chem. 2000, 275:22780-22789.
128. Selkoe D.J. Folding proteins in fatal ways. Nature 2003, 426:900-904.
129. Shembade N., Harhaj N.S., Liebl D.J., Harhaj E.W. Essential role for TAX1BP1 in the termination of TNF-α-, IL-1- and LPS-mediated NF-κB and JNK signaling. EMBO J. 2007, 26:3910-3922.
130. Shen X., Ying H., Qiu Y., Park J.S., Shyam R., Chi Z.L., et al. Processing of optineurin in neuronal cells. J. Biol. Chem. 2011, 286:3618-3629.
131. Siris E.S. Paget's disease of bone. J. Bone Miner. Res. 1998, 13:1061-1065.
132. Spudich G., Chibalina M.V., Au J.S., Arden S.D., Buss F., Kendrick-Jones J. Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to Disabled-2 and PtdIns(4,5)P2. Nat. Cell Biol. 2007, 9:176-183.
133. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
134. Stenmark H., Olkkonen V.M. The Rab GTPase family. Genome Biol. 2001, 2. REVIEWS3007.
135. Stieber A., Gonatas J.O., Gonatas N.K. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus. J. Neurol. Sci. 2000, 173:53-62.
136. Stone E.M., Fingert J.H., Alward W.L., Nguyen T.D., Polansky J.R., Sunden S.L., et al. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
137. Strick D.J., Elferink L.A. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Mol. Biol. Cell 2005, 16:5699-5709.
138. Stroissnigg H., Repitz M., Miloloza A., Linhartova I., Beug H., Wiche G., et al. FIP-2, an IκB-kinase-γ-related protein, is associated with the Golgi apparatus and translocates to the marginal band during chicken erythroblast differentiation. Exp. Cell Res. 2002, 278:133-145.
139. Sudhakar C., Nagabhushana A., Jain N., Swarup G. NF-κB mediates tumor necrosis factor α-induced expression of optineurin, a negative regulator of NF-κB. PLoS One 2009, 4:e5114.
140. Tang S., Toda Y., Kashiwagi K., Mabuchi F., Iijima H., Tsukahara S., et al. The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene. Hum. Genet. 2003, 113:276-279.
141. Theunissen O., Rudt F., Guddat U., Mentzel H., Pieler T. RNA and DNA binding zinc fingers in Xenopus TFIIIA. Cell 1992, 71:679-690.
142. Toda Y., Tang S., Kashiwagi K., Mabuchi F., Iijima H., Tsukahara S., et al. Mutations in the optineurin gene in Japanese patients with primary open-angle glaucoma and normal tension glaucoma. Am. J. Med. Genet. A 2004, 125A:1-4.
143. Todde V., Veenhuis M., van der Klei I.J. Autophagy: principles and significance in health and disease. Biochim. Biophys. Acta 2009, 1792:3-13.
144. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 2003, 424:793-796.
145. Uranishi H., Tetsuka T., Yamashita M., Asamitsu K., Shimizu M., Itoh M., et al. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-κB p65-mediated transcription as a coactivator. J. Biol. Chem. 2001, 276:13395-13401.
146. van Blitterswijk M., van Vught P.W.J., van Es M.A., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 2011, (in press).
147. van Staa T.P., Selby P., Leufkens H.G., Lyles K., Sprafka J.M., Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J. Bone Miner. Res. 2002, 17:465-471.
148. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
149. Vassilieva E.V., Nusrat A. Vesicular trafficking: molecular tools and targets. Methods Mol. Biol. 2008, 440:3-14.
150. Wang N., Chintala S.K., Fini M.E., Schuman J.S. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat. Med. 2001, 7:304-309.
151. Warner C.L., Stewart A., Luzio J.P., Steel K.P., Libby R.T., Kendrick-Jones J., et al. Loss of myosin VI reduces secretion and the size of the Golgi in fibroblasts from Snell's waltzer mice. EMBO J. 2003, 22:569-579.
152. Weidberg H., Shvets E., Shpilka T., Shimron F., Shinder V., Elazar Z. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 2010, 29:1792-1802.
153. Weisschuh N., Neumann D., Wolf C., Wissinger B., Gramer E. Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. Mol. Vis. 2005, 11:284-287.
154. Wiggs J.L. Genetic etiologies of glaucoma. Arch. Ophthalmol. 2007, 125:30-37.
155. Wiggs J.L., Auguste J., Allingham R.R., Flor J.D., Pericak-Vance M.A., Rogers K., et al. Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma. Arch. Ophthalmol. 2003, 121:1181-1183.
156. Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011, 333:228-233.
157. Willoughby C.E., Chan L.L., Herd S., Billingsley G., Noordeh N., Levin A.V., et al. Defining the pathogenicity of optineurin in juvenile open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2004, 45:3122-3130.
158. Wu C.J., Conze D.B., Li T., Srinivasula S.M., Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. 2006, 8:398-406. [corrected].
159. Xiao Z., Meng Q., Tsai J.C., Yuan H., Xu N., Li Y. A novel optineurin genetic mutation associated with open-angle glaucoma in a Chinese family. Mol. Vis. 2009, 15:1649-1654.
160. Yen Y.C., Yang J.J., Chou M.C., Li S.Y. Absence of optineurin (OPTN) gene mutations in Taiwanese patients with juvenile-onset open-angle glaucoma. Mol. Vis. 2008, 14:487-494.
161. Ying H., Shen X., Park B.C., Yue B.Y.J.T. Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene. PLoS One 2010, 5:e9168.
162. Yla-Anttila P., Vihinen H., Jokitalo E., Eskelinen E.L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 2009, 5:1180-1185.
163. Zerial M., McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001, 2:107-117.
164. Zhu G., Wu C.J., Zhao Y., Ashwell J.D. Optineurin negatively regulates TNFalpha-induced NF-κB activation by competing with NEMO for ubiquitinated RIP. Curr. Biol. 2007, 17:1438-1443.